(R)-(-)-1-Cbz-3-pyrrolidinol
97%
- Product Code: 229922
Alias:
(R)-1-benzyloxycarbonyl-3-hydroxypyrrolidine
CAS:
100858-33-1
| Molecular Weight: | 221.25 g./mol | Molecular Formula: | C₁₂H₁₅NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD07368258 | |
| Melting Point: | 74-79 °C | Boiling Point: | |
| Density: | Storage Condition: | Room temperature |
Product Description:
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its hydroxyl and protected amine functional groups allow for selective modifications, making it valuable in constructing complex molecules such as neuroactive drugs and antiviral agents. Commonly employed in medicinal chemistry for the preparation of pyrrolidine-based drug candidates, including those targeting central nervous system disorders. Also utilized in asymmetric synthesis and as an intermediate in the production of protease inhibitors.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Light orange to Yellow to Green powder to crystal |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿310.00 |
+
-
|
| 5.000 | 10-20 days | ฿580.00 |
+
-
|
| 25.000 | 10-20 days | ฿2,150.00 |
+
-
|
| 100.000 | 10-20 days | ฿8,100.00 |
+
-
|
| 500.000 | 10-20 days | ฿39,900.00 |
+
-
|
(R)-(-)-1-Cbz-3-pyrrolidinol
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its hydroxyl and protected amine functional groups allow for selective modifications, making it valuable in constructing complex molecules such as neuroactive drugs and antiviral agents. Commonly employed in medicinal chemistry for the preparation of pyrrolidine-based drug candidates, including those targeting central nervous system disorders. Also utilized in asymmetric synthesis and as an intermediate in the production of protease inhibitors.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :